Related Experiment Video
Updated: Aug 17, 2026

In vivo Evaluation of Mucociliary Clearance in Mice
Published on: December 18, 2020
Paranasal mucoceles in children with cystic fibrosis
Maurizio Di Cicco1, Diana Costantini, Rita Padoan
1ENT Department, Fondazione IRCCS Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, MD Cystic Fibrosis Centre via Commenda 9, University of Milan, 20122 Milan, Italy. maurimdc@yahoo.com
Insights
Sinus mucoceles are more common in children with Cystic Fibrosis (CF) than previously thought. Endoscopic sinus surgery is a safe and effective treatment for this condition in young CF patients.
Area of Science:
- Otorhinolaryngology
- Pediatric Pulmonology
- Medical Imaging
Background:
- Sinus mucoceles are uncommon in children, with limited data on their prevalence in Cystic Fibrosis (CF) patients.
- Endoscopic sinus surgery (ESS) is established for adult sinus mucoceles, but its pediatric efficacy in CF is less understood.
Purpose of the Study:
- To determine the prevalence of sinus mucoceles in pediatric CF patients with chronic upper airway disease (CUAD).
- To evaluate the safety and efficacy of ESS for sinus mucoceles in young CF patients.
Main Methods:
- A cohort of 242 pediatric CF patients (born 1990-2001) was screened for CUAD symptoms.
- 90 symptomatic patients underwent ENT examination; 15 had CT scans, diagnosing 9 mucoceles (16.4% prevalence).
- All diagnosed mucoceles were treated with ESS, with follow-up ranging from 3 months to 6 years.
Main Results:
- Sinus mucoceles were diagnosed in 9 out of 55 symptomatic pediatric CF patients (16.4% prevalence).
- The median age at diagnosis was 4 years.
- Endoscopic sinus surgery showed no recurrence during the follow-up period.
Conclusions:
- Sinus mucoceles are a notable complication in pediatric CF patients, requiring a high index of suspicion.
- Endoscopic sinus surgery is a safe and effective treatment for sinus mucoceles in this high-risk pediatric population.
Abstract:
Sinus mucocele is rare in the paediatric age, and so far no prevalence data have been reported in children with Cystic Fibrosis (CF). Moreover, safety and efficacy of endoscopic management of sinus mucoceles has been widely proven but only in the adult population. The aim of our study was to evaluate the prevalence of this complication and the efficacy of endoscopic sinus surgery in CF patients during the initial years of life. Among the 242 CF patients born in the period between 1990 and 2001 and in regular follow up at our CF Centre, 90 patients with possible symptoms of chronic upper airways disease (CUAD) underwent a comprehensive ENT examination including rhinofibroscopy. In selected cases a CT scan of the paranasal sinuses was also performed. CUAD was diagnosed in 55/90 because of the consistent presence of nasal obstruction, combined with at least two other nasal symptoms such as chronic nasal discharge, snoring, epiphora. Diagnosis of mucoceles (five maxillary bilateral mucoceles, one maxillary unilateral, three maxillary and etmoidal mucoceles) was done by means of CT scan in 9/15 who performed the examination. Median age at the diagnosis was 4+/-0.5 years, ranging from 0.5+/-7 years, showing a prevalence of 16.4% (9/55) among patients with symptoms. Endoscopic sinus surgery was performed in all the cases. The follow-up period ranged from 3 months to 6 years with no recurrence observed. Sinus mucocele in CF population is less unusual than expected and a high degree of suspicion is needed. Endoscopic sinus surgery seems to be a safe and efficient treatment of this complication also in a paediatric population at a high risk as for the CF patients.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Nose and Nasal Cavity
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Cryptococcal Meningitis
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Microbiota of the Respiratory Tract